Using melanoma as a model, lower expression of MEX-3B correlated with response to checkpoint blockade, with an antibody directed against the programed cell death 1 (PD-1) receptor, while MEX-3B overexpression inhibited T cell-mediated tumor elimination. Here, PDCD1 is linked to melanoma.